The use of predialysis glucose as long term glycemic marker in hemodialysis patients

Abstract

Aim: The major cause of chronic renal disease (CRD) is diabetes mellitus (DM). Although there are some other long term glycemic markers available, HbA1c remains the gold standart in CRD. In this study we aimed to explore the relation between average predialysis glucose and HbA1c levels. Material and Method: 101 diabetic hemodialysis patients from two centers were included in this study. Last 2 and 3 months’ average predialysis glucose levels were obtained. After 3 months, HbA1c levels were also studied. Results: A significant and strong correlation between HbA1c and both 2 and 3 months’ average predialysis glucose levels were found (p